Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Markey Cancer Center Research Day 2021


NOTICE: To protect the health of our attendees – and to follow the novel coronavirus (COVID-19) guidelines implemented by national, state and local governments – the Markey Cancer Center Research Day (MCCRD) 2021 will be held online.

Markey Cancer Center Research Day is a single-day event showcasing current cancer research projects throughout all disciplines at the University of Kentucky and will be held May 18, 2021, in an online format. 

For the eleventh year, the UK research community will have the opportunity to share its work in an atmosphere of learning and collaboration throughout the day via:

  • Oral presentations (invited from abstract submissions)
  • State of the Cancer Center Address, by B. Mark Evers, MD, Director, Markey Cancer Center
  • Susan B. Lester Memorial Lecture, presented by Douglas R. Lowy, MD, Principal Deputy Director, National Cancer Institute.
  • Gilbert H. Friedell, MD Memorial Lecture, presented by Edward E. Partridge, MD, Director Emeritus, University of Alabama at Birmingham O’Neal Comprehensive Cancer Center.


New for this year’s event are a shortened agenda and an expansion of the student/trainee oral presentations.  Researchers will submit their abstracts online using the link below.  From the submitted abstracts, multiple students and trainees will be selected for oral presentations and cash awards in such categories such as basic science, clinical, translational and population research.  Winners of the oral presentation submissions will receive cash awards of up to $200. 

A program booklet will be compiled from those submissions; however, the traditional poster presentations will not be held this year. 

Presented by the Markey Cancer Center and the UK Markey Cancer Foundation.

  • About Susan B. Lester

    Susan B. Lester
    Susan B. Lester

    The family and friends of Susan B. Lester endowed a lectureship in her honor, and it is this generous donation that makes the Markey Cancer Center Research Day possible.

    Mrs. Lester left an indelible mark on her world, serving as a clinical dietician for Eastern State Hospital and for nursing home patients in Eastern and Central Kentucky.

    This symposium benchmarks recent advances in cancer research and thus honors Mrs. Lester by underscoring both her generous life and the brave battle she fought against this disease.

  • 2021 Susan B. Lester Memorial Lecture

    Doug Lowy, MD
    Doug Lowy, MD

    Keynote Presentation

    Douglas R. Lowy, MD
    Principal Deputy Director, National Cancer Institute
    Chief, Laboratory of Cellular Oncology
    NIH Distinguished Investigator
    Head, Signaling and Oncogenesis Section

    Learn more about Dr. Lowy.

    Dr. Lowy currently serves as Acting Director of the National Cancer Institute. As Laboratory Chief, Dr. Lowy’s two main research areas focus on basic and translational aspects of human papillomavirus infection and on cancer genes. His joint research with John Schiller has identified many aspects of the human papillomavirus (HPV) life cycle, developed technology underlying the FDA-approved HPV vaccines, and elucidated mechanisms for the high efficacy of the vaccines. His joint research with John Schiller in the Laboratory of Cellular Oncology (LCO) has identified many aspects of the HPV life cycle, developed technology underlying the FDA-approved HPV vaccines, and elucidated mechanisms for the high efficacy of the vaccines. Secondly, his research is currently examining the DLC1 tumor suppressor, which encodes a Rho-GAP that is down-regulated in a wide variety of cancers, leading to the high Rho activity seen in many advanced cancers. This research has identified important scaffold functions for DLC1, including protein-protein interactions that contribute to the regulation of its activity and its role as a tumor suppressor, and identified kinases that activate and inactivate the functions of DLC1 and the mechanisms by which they do so.

  • About Gilbert H. Friedell

    Dr. Friedell
    Dr. Gilbert H. Friedell

    In 1983, Dr. Friedell became the first director of the UK Markey Cancer Center, beginning a legacy of cancer care that continues to grow and make a difference in the lives of Kentuckians every day. At Markey, he co-founded the Kentucky Cancer Registry – now one of the premiere SEER databases in the country – and served as the principal investigator of the National Cancer Institute’s Mid-South Cancer Information Service, a cancer education program that provides easy-to-understand information for cancer patients, survivors, health care providers and more.

    Dr. Friedell was a passionate advocate for programs that provided education and increased access to healthcare for the medically underserved, particularly in Appalachian Kentucky. He famously believed that “If the problems are in the community, the solutions are in the community.” With this in mind, he helped launch Kentucky Homeplace, an initiative that has linked tens of thousands of rural Kentuckians with medical, social and environmental services since it began in 1994.

    Though he retired from UK in 2000, Dr. Friedell’s influence is still felt strongly in the overarching mission of our cancer center: to conquer cancer in the Commonwealth. We at Markey are proud to uphold the vision and values of Dr. Friedell, building upon his contributions to public health as we continue to care for Kentuckians with cancer.

  • 2021 Gilbert H. Friedell, MD, Memorial Lecture

    Edward E. Partridge, MD
    Edward E. Partridge, MD

    Gilbert H. Friedell, MD, Memorial Lecture

    Edward E. Partridge, MD
    Director, University of Alabama at Birmingham

    Learn more about Dr. Partridge.

    Dr. Partridge is currently the Director of the UAB Comprehensive Cancer Center, a center with a long and rich history addressing issues of cancer disparities through research and service in both rural and inner-city underserved communities. His cancer control research is focused on health disparities. He currently serves as PI for the Deep South Cancer Control Network, addressing age-appropriate screening, healthy eating and physical activity in traditionally underserved, rural and inter-city African American populations in Alabama and Mississippi. He previously served as PI and is the current Co-PI of the Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership, which conducts both basic and applied research in cancer disparities and focuses on training of minority investigators. He is also the PI of the partnership with Johns Hopkins for a Cervical Specialized Progress of Research Excellence (SPORE) and previously served as PI for the Ovarian SPORE at UAB. He recently was awarded a large grant from Centers for Medicare and Medicaid Services to study the utilization of lay navigators across the UAB Cancer Care Network and across the continuum of disease through treatment, survivorship and end of life. Through his leadership of the Mid-South Division of the American Cancer Society, where he served as Chairman, ACS has focused on reducing and eliminating cancer disparities. As President of the American Cancer Society National Board of Directors, he provided leadership for the development of mission priorities that address cancer disparities.

  • Agenda

    NOTICE: To protect the health of our attendees – and to follow the novel coronavirus (COVID-19) guidelines implemented by national, state and local governments – the Markey Cancer Center Research Day (MCCRD) 2021 will be held online.

    May 18, 2021

    9:00 am – 9:15 am      Welcome

    9:15 am – 10:45 am    Student/Trainee Oral Presentations, Mentorship Award

    10:45 am – 11:45 am  Susan B. Lester Lecture by Dr. Douglas Lowy

    1:00 pm – 1:05 pm     Markey Women Strong Awards, Markey Cancer Foundation 

    1:05 pm – 1:35 pm     “State of the Cancer Center Address,” by Dr. B. Mark Evers

    1:35 pm – 1:40 pm     Introductory Remarks

    1:40 pm – 2:40 pm     Gilbert H. Friedell, MD, Memorial Lecture by Dr. Edward Partridge

  • Abstract and Poster Guidelines

    In lieu of the traditional poster presentations, MCCRD 2021 will expand opportunities for students/trainees to give oral presentations in the morning session – based on their abstract submissions.  The submission form for the abstracts remains the same as for the posters, although no posters will need to be created.  (Student/trainee researchers also may choose not to have their abstracts considered for the oral presentation prizes, but their abstracts will be included in the program booklet.)  Abstracts are limited to 525 words or less.

    Visit the Call for Abstracts Submission Form online. 


    Contact the event coordinator via email at